Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Feb;7(2):133–138. doi: 10.1128/aac.7.2.133

Acute Pelvic Inflammatory Disease and Clinical Response to Parenteral Doxycycline

Anthony W Chow *, Kay L Malkasian †,‡, John R Marshall †,‡, Lucien B Guze †,‡
PMCID: PMC429092  PMID: 1169908

Abstract

The bacteriology of acute pelvic inflammatory disease (PID) and clinical response to parenteral doxycycline were evaluated in 30 patients. Only 3 of 21 cul-de-sac cultures from PID patients were sterile, whereas all 8 normal control subjects yielded negative results (P< 0.005). Poor correlation was observed between cervical and cul-de-sac cultures. Neisseria gonorrhoeae, isolated from the cervix in 17 patients (57%), was recovered from the cul-de-sac only once. Streptococcus, Peptococcus, Peptostreptococcus, coliforms, and other organisms normally present in the vagina were the predominant isolates recovered from the cul-de-sac. Parenteral doxycycline resulted in rapid resolution of signs and symptoms (within 48 h) in 20 of 27 evaluable patients (74%). In five others, signs and symptoms of infection abated within 4 days. The remaining two patients failed to respond; in both cases, adnexal masses developed during doxycycline therapy. Gonococci were eradicated from the cervix in all but one patient who, nevertheless, had a rapid defervescence of symptoms. There was no clear-cut correlation between the clinical response and in vitro susceptibility of cul-de-sac isolates to doxycycline. These data confirm the usefulness of broad-spectrum antibiotics in acute PID. Culdocentesis is a reliable means of obtaining material for the bacteriological diagnosis of acute PID; however, the pathogenetic role and relative importance of gonococci and various other bacteria in acute PID need to be clarified further.

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G., Finegold S. M. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis. 1974 Jul;110(1):56–77. doi: 10.1164/arrd.1974.110.1.56. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Chow A. W., Montgomerie J. Z., Guze L. B. Parenteral clindamycin therapy for severe anaerobic infections. Arch Intern Med. 1974 Jul;134(1):78–82. [PubMed] [Google Scholar]
  4. English A. R. Alpha-6-deoxyoxytetracycline. I. Some biological properties. Proc Soc Exp Biol Med. 1966 Aug-Sep;122(4):1107–1112. doi: 10.3181/00379727-122-31338. [DOI] [PubMed] [Google Scholar]
  5. Fabre J., Milek E., Kalfopoulos P., Mérier G. La cinétique des tétracyclines chez l'homme. II. Excrétion, pénétration dans les tissus normaux et inflammatoires, comportement en cas d'insuffisance rénale et d'hémodialyse. Schweiz Med Wochenschr. 1971 May 8;101(18):625–633. [PubMed] [Google Scholar]
  6. Falk V. Treatment of acute non-tuberculous salpingitis with antibiotics alone and in combination with glucocorticoids. A prospective double blind controlled study of the clinical course and prognosis. Acta Obstet Gynecol Scand. 1965;44(Suppl):3–118. doi: 10.3109/00016346509158538. [DOI] [PubMed] [Google Scholar]
  7. Garnes H. A. Doxycycline levels in serum and prostatic tissue in man. Urology. 1973 Mar;1(3):205–207. doi: 10.1016/0090-4295(73)90736-x. [DOI] [PubMed] [Google Scholar]
  8. Gorbach S. L., Thadepalli H. Clindamycin in pure and mixed anaerobic infections. Arch Intern Med. 1974 Jul;134(1):87–92. [PubMed] [Google Scholar]
  9. Isenberg H. D. In vitro activity of doxycycline against bacteria from clinical material. Appl Microbiol. 1967 Sep;15(5):1074–1078. doi: 10.1128/am.15.5.1074-1078.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Leibowitz B. J., Hakes J. L., Cahn M. M., Levy E. J. Doxycycline blood levels in normal subjects after intravenous and oral administration. Curr Ther Res Clin Exp. 1972 Dec;14(12):820–832. [PubMed] [Google Scholar]
  11. Mahon W. A., Wittenberg J. V., Tuffnel P. G. Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function. Can Med Assoc J. 1970 Nov 7;103(10):1031–1034. [PMC free article] [PubMed] [Google Scholar]
  12. Mead P. B., Louria D. B. Antibiotics in pelvic infections. Clin Obstet Gynecol. 1969 Mar;12(1):219–239. doi: 10.1097/00003081-196903000-00012. [DOI] [PubMed] [Google Scholar]
  13. Steigbigel N. H., Reed C. W., Finland M. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci. 1968 Mar;255:179–195. doi: 10.1097/00000441-196803000-00005. [DOI] [PubMed] [Google Scholar]
  14. Swenson R. M., Michaelson T. C., Daly M. J., Spaulding E. H. Anaerobic bacterial infections of the female genital tract. Obstet Gynecol. 1973 Oct;42(4):538–541. doi: 10.1097/00006250-197310000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES